XML 108 R91.htm IDEA: XBRL DOCUMENT v3.22.4
Loss per Common Share - Computation of Earnings per Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
 3 Months Ended 12 Months Ended
Dec. 31, 2022
Sep. 30, 2022
Jun. 30, 2022
Mar. 31, 2022
Dec. 31, 2021
Sep. 30, 2021
Jun. 30, 2021
Mar. 31, 2021
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Earnings Per Share [Abstract]                      
Loss from continuing operations                 $ (18,701) $ (30,284) $ (328,172)
Loss from discontinued operations, net of tax [1]                 (463) (7,317) (6,074)
Net loss attributable to common shareholders of Evolent Health, Inc - Basic $ (11,349) $ 2,123 $ (4,588) $ (5,350) $ (5,647) $ (13,040) $ (9,107) $ (9,807) (19,164) (37,601) (334,246)
Net loss attributable to common shareholders of Evolent Health, Inc. - Diluted $ (11,349) $ 2,123 $ (4,588) $ (5,350) $ (5,647) $ (13,040) $ (9,107) $ (9,807) $ (19,164) $ (37,601) $ (334,246)
Weighted-average common shares outstanding - basic (in shares)                 93,699 86,067 84,928
Weighted-average common shares outstanding - diluted (in shares)                 93,699 86,067 84,928
Basic and diluted:                      
Continuing operations, basic (in dollars per share) $ (0.11) $ 0.02 $ (0.05) $ (0.06) $ 0.03 $ (0.15) $ (0.11) $ (0.13) $ (0.20) $ (0.35) $ (3.86)
Continuing operations, diluted (in dollars per share) (0.11) 0.02 (0.05) (0.06) 0.03 (0.15) (0.11) (0.13) (0.20) (0.35) (3.86)
Discontinued operations, basic (in dollars per share) 0 0 0 0 (0.09) 0 0 0.01 0 (0.09) (0.08)
Discontinued operations, diluted (in dollars per share) $ 0 $ 0 $ 0 $ 0 $ (0.09) $ 0 $ 0 $ 0.01 0 (0.09) (0.08)
Basic loss per share attributable to common shareholders of Evolent Health, Inc. (in dollars per share)                 (0.20) (0.44) (3.94)
Diluted loss per share attributable to common shareholders of Evolent Health, Inc. (in dollars per share)                 $ (0.20) $ (0.44) $ (3.94)
[1] Includes $0.5 million and $6.8 million of loss on disposal of discontinued operations for years ended December 31, 2022 and 2021, respectively